September 30, 2021
GlaxoSmithKline’s recently approved COVID-19 antibody drug Xevudy (sotrovimab) will be placed outside the normal distribution channel in Japan for now due to its limited supplies, with the product to be allocated to medical institutions through the government. The Ministry of...read more